Feb 13, 2017 12:01 pm UTC| Business
NEW YORK, Feb. 13, 2017 -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment...
Feb 13, 2017 12:01 pm UTC| Business
NEW YORK, Feb. 13, 2017 -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment...
Feb 13, 2017 12:01 pm UTC| Business
Saphyr brings comprehensive structural variation detection with industry-leading sensitivity, specificity at high speed and high throughput To be showcased at the AGBT General Meeting this week SAN DIEGO, Feb. 13, 2017...
Feb 13, 2017 12:01 pm UTC| Business
Saphyr brings comprehensive structural variation detection with industry-leading sensitivity, specificity at high speed and high throughput To be showcased at the AGBT General Meeting this week SAN DIEGO, Feb. 13, 2017...
NewLink Genetics to Participate in 2017 SunTrust Orphan Drug Day on February 14th
Feb 13, 2017 12:01 pm UTC| Business
AMES, Iowa, Feb. 13, 2017 -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with cancer, today announced that it will participate...
NewLink Genetics to Participate in 2017 SunTrust Orphan Drug Day on February 14th
Feb 13, 2017 12:01 pm UTC| Business
AMES, Iowa, Feb. 13, 2017 -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with cancer, today announced that it will participate...
Protalix BioTherapeutics to Participate in the 13th Annual WORLDSymposium™ 2017
Feb 13, 2017 12:01 pm UTC| Business
Data to be presented in three oral presentations and two poster presentations CARMIEL, Israel, Feb. 13, 2017 -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), announced today that the Company will...